Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease
Konstantinos A. Papadakis, Barry Rosenbloom, Stephan R. TarganVolume:
124
Year:
2003
Language:
english
DOI:
10.1053/gast.2003.50081
File:
PDF, 54 KB
english, 2003